The Company is a pharmaceutical company that operates in two business segments.
The Company is a pharmaceutical company that operates in two business segments. The Medical and Related Product segment, along with its subsidiaries and associated companies, mainly manufactures and sells pharmaceuticals and related products in Japan, as well as the United States, Brazil, Vietnam, China and Indonesia. The Others segment is engaged in the urban cable television broadcasting business and Internet connection service business, the sale and rearing of experimental animals, the sale of experimental equipment and materials, the purchase, manufacture and sale of packing materials, the non-life insurance agency business and advertising agency business, among others. The Company was founded in 1847 and established on May 22, 1944 and its was changed the name to present name in April 1965. Its shares were listed on the second section of Tokyo Stock Exchange and Fukuoka Stock Exchange in September 1962. Its shares also listed on the second section of Osaka Stock Exchange in August 1964 and listed on the second section of Nagoya Stock Exchange in September 1971 and both shares listings later was transferred to the first section of Tokyo Stock Exchange and the first section of Nogoya Stock Exchange and the first section of Osaka Stock Exchange in July 1972. It has delisted from Osaka Stock Exchange in July 2010.